Abnormal fatty acid metabolism and dyslipidemia play an intimate role in the pathogenesis
of metabolic syndrome and cardiovascular diseases. The availability of glucose and insulin …

Structured lifestyle interventions can reduce diabetes incidence and cardiovascular disease
(CVD) risk among persons with impaired glucose tolerance (IGT), but it is unclear whether …

We recently proposed that the biological markers improved by carbohydrate restriction were
precisely those that define the metabolic syndrome (MetS), and that the common thread was …

A wide range of biomarkers, reflecting activity in a number of biological systems (eg,
neuroendocrine, immune, cardiovascular, and metabolic), have been found to prospectively …

Background This review provides a reappraisal of the potential effects of dairy foods,
including dairy fats, on cardiovascular disease (CVD)/coronary heart disease (CHD) risk …

Diabetes mellitus (DM) is a chronic endocrine disease resulted from insulin secretory defect
or insulin resistance and it is a leading cause of death around the world. The care of DM …

Reduced levels of high‐density lipoproteins (HDL) in non‐obese and obese states are
associated with increased risk for the development of coronary artery disease. Therefore, it …

Background: Evidence for an association between total cholesterol, low-and high-density
lipoproteins (LDL and HDL, respectively), triglycerides, and prostate cancer is conflicting …

Background Epidemiologic evidence for a serum cholesterol-prostate cancer link is mixed.
Prostate-specific antigen (PSA) is positively correlated with cholesterol, potentially …

Objectives: We sought to evaluate the significance of high-density lipoprotein cholesterol
(HDL-C) in the context of low low-density lipoprotein cholesterol (LDL-C). Background …